Treatment of refractory adult acute leukemia with 5-azacytidine plus beta-2'-deoxythioguanosine.
D000293:Adolescent; D000328:Adult; D001374:Azacitidine / Q000008:administration & dosage*; D003849:Deoxyguanosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013872:Thionucleosides / Q000008:administration & dosage*; D013997:Time Factors
D013872:Thionucleosides; C010438:beta-2'-deoxythioguanosine; D003849:Deoxyguanosine; D001374:Azacitidine